Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biotech Turnaround Fund (BTF) is a specialized venture capital firm based in the Netherlands that focuses on investing in and revitalizing distressed or underperforming biotechnology companies. The fund provides not only financial capital but also hands-on operational and strategic management to help portfolio companies overcome clinical, financial, or organizational hurdles. By targeting late-stage assets or companies with proven technology that require a 'turnaround' strategy, BTF aims to bridge the gap between development setbacks and commercial success. Their investment approach typically involves taking significant stakes to influence corporate direction and maximize the value of therapeutic pipelines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biotech Turnaround Fund.